Skip to content

    Shree Pushkar Chemicals & Fertilisers Q1 FY27 earnings call

    SHREEPUSHK
    Chemicals·13 Aug 2026
    Management Summary

    Shree Pushkar Chemicals & Fertilisers Limited reported a positive Q1 FY27 with 10% YoY revenue growth and improved profitability, despite lower sales volumes across both chemical and fertilizer segments. The company continued its expansion initiatives, including nearing completion of Ratnagiri Units 5 & 6 and progressing on Meghnagar expansion, alongside a strategic land acquisition. Management expressed optimism for FY27, projecting higher turnover and PAT margins, driven by value realization and anticipated volume recovery.

    Highlights

    5
    • Revenue from operations grew by 10% year-on-year to Rs. 281.1 crores, despite challenges.

    • EBITDA increased by 9.7% year-on-year to Rs. 31.9 crores, with a margin of 11.4%.

    • Profit after tax grew by 9.4% to Rs. 22.9 crores, with a margin of 8.2%.

    • Chemical business reported sales value growth of 17.10% year-on-year to Rs. 138 crores.

    • Acquired 30,000 square meters of additional land for Rs. 9.33 crores for future expansion.

    Concerns

    4
    • Overall sales volume across both businesses were lower during the quarter.

    • Fertilizer business sales volume declined from 76,288 metric tons in Q1 FY26 to 66,527 metric tons in Q1 FY27.

    • Chemical business sales volume declined from 14,837 metric tons in Q1 FY26 to 9,113 metric tons in Q1 FY27.

    • Dyes and chemicals utilization levels decreased due to the global scenario and focus on value over volume.

    Key financials

    Single quarter

    07 metrics
    1. 01Revenue from Operations₹281.1 Cr+10%YoY
    2. 02Gross Profit₹89.2 Cr+6.3%YoY
    3. 03Gross Profit Margin31.9%
    4. 04EBITDA₹31.9 Cr+9.7%YoY
    5. 05EBITDA Margin11.4%

    Segment breakdown

    • Fertilizer Business66,527 metric tons88.0%
    • Chemical Business9,113 metric tons12.0%
    Donut· Share of Sales Volume

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹20 crores this quarter · ₹512 crores (FY27) planned

    through the internal accruals and proceeds from the preferential issue

    M&A

    Additional land at Lote Parshuram

    acquisition · closed · Consideration ₹9.33 crores

    Liquidity

    Cash ₹125 crores

    Comfortable position with non-lien deposits.

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Turnover
    close to Rs. 1,250 crores
    High
    Revenue
    Turnover
    Rs. 1,350 crores or Rs. 1,400 crores
    Medium
    Revenue
    Turnover
    crossing 1,700 to 1,750
    Medium
    Profitability
    PAT levels
    near to the 9% or so
    High
    Operations
    Unit 5 and Unit 6 trials
    go on trials
    High

    What to watch in Q2 FY27

    5

    Unit 5 and Unit 6 commissioning and trial operations

    Next month or month and a half (from August 2026)
    CurrentNearing completion, preparations made
    TargetGo on trials, 4-5 months of operation for FY27

    Why it matters

    Commercialization of new capacities is key for future revenue and profitability growth.

    I expect that in the next month or month and a half, we should go on trials. So, you can assume that for this year, we will have four to five months of operation for Unit 6 and the Unit 5 dyes unit.

    Risks & concerns

    3
    RiskSeverity

    Raw material price volatility and supply chain challenges

    The company's performance was achieved despite continued challenges around global supply chain and elevated raw material prices. Sulfur prices increased from USD250-300 to USD1100.Management acknowledged

    medium

    Working capital stress due to raw material payment terms vs. finished goods credit

    Sulfur requires advance payment, while acid is sold entirely on credit, leading to working capital stress. This led to acid plants operating at low load.Management acknowledged

    medium

    Lower sales volumes in Q1 FY27 across both businesses

    Sales volume across both the fertilizer and chemical businesses were lower due to market conditions and consumer pause following the West Asia conflict.Management acknowledged

    medium

    Q&A highlights

    8

    “In my opinion, if you see that during Q1 FY2026-FY2027, in spite of low volumes, we have done a better value realization. The most important part in the whole business, what I understand, is adding the values to the business and making money for the company and for the shareholders... I believe this year will be much better than the last two or three financial years for the company.”

    Management provides a positive outlook for the year despite Q1 volume decline, emphasizing value realization and improved margins.

    asked by Saket Kapoor

    3 min read6 chapters

    Detailed Narrative

    01

    Q1 FY27 Performance Overview

    Shree Pushkar Chemicals & Fertilisers Limited commenced FY27 on a positive note, reporting a 10% year-on-year revenue growth to Rs. 281.1 crores, driven by improved realization despite lower sales volumes. Profitability also saw an uplift, with EBITDA increasing by 9.7% YoY to Rs. 31.9 crores (11.4% margin) and PAT growing by 9.4% to Rs. 22.9 crores (8.2% margin). Gross profit stood at Rs. 89.2 crores, up 6.3% YoY, with a margin of 31.9%.

    02

    Capacity Expansion & Infrastructure Development

    The company is actively progressing with its expansion initiatives, including Ratnagiri Unit 5 and Unit 6, which are in advanced stages of completion, and the Meghnagar expansion. These projects are expected to significantly expand manufacturing capabilities, adding 450,000 metric tons per annum of fertilizer capacity and 72,000 metric tons per annum of chemical capacity. Additionally, Shree Pushkar acquired 30,000 square meters of land at Lote Parshuram for Rs. 9.33 crores, strategically located near existing Unit 1, to support long-term capacity plans.

    03

    Raw Material Dynamics & Pricing Strategy

    Shree Pushkar faced continued challenges from elevated raw material prices and supply chain issues, with sulfur prices surging from USD250-300 to USD1100. To mitigate this, the company strategically operated its acid plants at low load, prioritizing value realization and managing working capital, as sulfur requires advance payment while acid is sold on credit. Management noted an improvement in raw material availability compared to previous months, which is crucial for future production.

    04

    Segmental Performance & Volume Trends

    While overall sales volumes were lower in Q1 FY27, improved realizations helped offset this impact. The fertilizer business recorded a sales volume of 66,527 metric tons (down from 76,288 MT in Q1 FY26) but achieved a sales value of Rs. 142 crores, growing 4% YoY. The chemical business saw volumes decline to 9,113 metric tons (from 14,837 MT in Q1 FY26) but reported a sales value of Rs. 138 crores, a 17.10% YoY growth. Both segments contributed almost equally to the total sales value (51% fertilizer, 49% chemical).

    05

    Capital Expenditure & Renewable Energy Initiatives

    The company incurred approximately Rs. 20 crores in capex during Q1 FY27, bringing cumulative capex to Rs. 209 crores against a total planned capex of Rs. 512 crores. These investments are funded through internal accruals and preferential issue proceeds, ensuring financial flexibility. Furthermore, the 10-megawatt DC solar power project at Nanded is nearing completion, which will increase the company's total installed solar capacity to 20.6 megawatts on a DC basis, aligning with its sustainable operating model and integration strategy.

    06

    Outlook and Future Growth Targets

    Management expressed strong optimism for FY27, anticipating it to be significantly better than the previous two to three years. The company projects achieving a turnover of Rs. 1,350-1,400 crores for FY27, an upward revision from the earlier Rs. 1,250 crores, with PAT levels near 9%. For FY28, with a full year of Unit 6 operations, the company projects turnover could cross Rs. 1,700-1,750 crores. Unit 5 and Unit 6 are expected to commence trials within the next month to month and a half, contributing to operations for four to five months in FY27.

    This is an AI-generated summary of a publicly available earnings call transcript.